Biotech

All Articles

Praxis epilepsy medicine reduces confiscations in phase 2 litigation

.Praxis Precision Medicines has racked up an additional midphase gain in epilepsy this year, along w...

Three officers surrender as Dyne messages combined data for DMD candidate

.After running away a clinical grip many years back, Dyne Therapeutics has actually disclosed new st...

Arrowhead fires off period 3 information in uncommon metabolic condition before market encounter Ionis

.Arrowhead Pharmaceuticals has actually revealed its own hand in advance of a prospective showdown w...

Pfizer, Valneva present lyme condition try effective for second enhancer

.Pfizer as well as Valneva may have concerning 2 additional years to hang around just before they he...

Fierce Biotech Editor-in-Chief Ayla Ellison Chats Shop with Michelle Benz on the Future of Biotech.

.Let's dive into a chat along with Ayla Ellison, Intense Biotech Managing Editor and also Michelle B...

New information demonstrate how Bayer's asundexian neglected to prevent strokes

.Bayer suspended the period 3 test for its own aspect XIa inhibitor asundexian late in 2015 after th...

Sanofi's tolebrutinib fails 2 of 3 late-stage MS tests

.Sanofi is still set on taking its numerous sclerosis (MS) med tolebrutinib to the FDA, executives h...

Galapagos' stockpile as fund shows intent to mold its own advancement

.Galapagos is actually happening under added tension coming from real estate investors. Having devel...

Cell- focused Sana gathers 1st CSO-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of substantial management hirings, shootings and...

Allist pays Jacobio $21M, landing task in Chinese KRAS nationality

.Shanghai Allist Pharmaceuticals has acquired itself a starring job in China's KRAS market, paying J...